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Electrochemical control of [FeFe]-hydrogenase
single crystals reveals complex redox populations
at the catalytic site†
Simone Morra, *‡a Jifu Duan, b Martin Winkler,b Philip A. Ash, §a
Thomas Happe b and Kylie A. Vincent *a
Elucidating the distribution of intermediates at the active site of redox metalloenzymes is vital to under-
standing their highly efficient catalysis. Here we demonstrate that it is possible to generate, and detect, the
key catalytic redox states of an [FeFe]-hydrogenase in a protein crystal. Individual crystals of the prototypical
[FeFe]-hydrogenase I from Clostridium pasteurianum (CpI) are maintained under electrochemical control,
allowing for precise tuning of the redox potential, while the crystal is simultaneously probed via Fourier
Transform Infrared (FTIR) microspectroscopy. The high signal/noise spectra reveal potential-dependent vari-
ation in the distribution of redox states at the active site (H-cluster) according to state-specific vibrational
bands from the endogeneous CO and CN− ligands. CpI crystals are shown to populate the same H-cluster
states as those detected in solution, including the oxidised species Hox, the reduced species Hred/HredH+,
the super-reduced HsredH+ and the hydride species Hhyd. The high sensitivity and precise redox control
offered by this approach also facilitates the detection and characterisation of low abundance species that
only accumulate within a narrow window of conditions, revealing new redox intermediates.
Introduction
[FeFe]-hydrogenases are redox active metalloenzymes that
reversibly catalyse the reduction of two protons (H+) to H2 at
high turnover rates via the H-cluster, a highly specialised iron
sulfur centre.1–3
The H-cluster (Fig. 1, top) comprises a cubane [4Fe4S] sub-
cluster, coordinated by four conserved cysteine residues, one
of which bridges to a [2Fe] sub-cluster. The [2Fe]-cluster is co-
ordinated by three CO, two CN− ligands and an azadithiolate
(adt) ligand in a bridging position between the Fe sites, which
are differentiated as proximal and distal (Fep and Fed) accord-
ing to their relative proximity to the [4Fe4S] cluster.4–6
The unique catalytic features of [FeFe]-hydrogenases arise
from the finely tuned synergy between the H-cluster and its
evolutionarily optimised protein environment.7–12 Taking
information from spectroscopy, structural studies and compu-
tational methods, several potential catalytic intermediates
(Fig. 1, bottom) have been described and partially character-
ised. Their relevance for the catalytic cycle and their exact
atomic structure are still under investigation.13–15
It is widely accepted that the H-cluster in the oxidised
‘ready’ state, Hox, displays a [4Fe4S]2+-Fe(II)Fe(I) configuration,
with one of its carbonyl ligands in a bridging position between
the two metal atoms (µCO), and a vacant axial coordination
site at the distal iron atom (marked by an asterisk in Fig. 1).16
Reversible binding of an additional CO molecule to Hox
results in HoxCO, an inhibited state of the H-cluster.17–19
A 1-electron reduction of the H-cluster in Hox yields the
reduced state Hred that features a similar geometry with a
[4Fe4S]1+-Fe(II)Fe(I) configuration.13,20,21 An alternative nomen-
clature refers to this species as Hred′.15,22
The protonated reduced state HredH+ (Hred according to
the alternative nomenclature) displays a [4Fe4S]2+-Fe(I)Fe(I)
configuration and can be obtained either by a single proton
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binding to Hred (with simultaneous intra-cluster electron trans-
fer from [4Fe4S] to Fep), or by proton-coupled electron transfer
(PCET) from Hox. The exact location of the additional proton,
and the reconfiguration of the bridging CO to a terminal posi-
tion, are currently debated: there is disagreement as to whether
the proton remains attached to the nitrogen atom of the aza-
dithiolate bridge or shifts to a location between the two iron
atoms forming a bridging hydride (µH−). Correspondingly it is
likewise unclear whether the µCO ligand remains in the brid-
ging position or shifts towards Fed, adopting an axial configur-
ation. Accordingly, the catalytic and mechanistic relevance of
HredH+ is under intense debate.13,14,20,23,24
A second 1-electron reduction step may generate the super-
reduced state HsredH+, exhibiting a [4Fe4S]1+-Fe(I)Fe(I) con-
figuration.25 Also in this case, consensus is lacking on the pro-
tonation state, the actual geometry, and the relevance for cata-
lytic turnover.14
Alternatively, the second 1-electron reduction step may
generate the key catalytic intermediate Hhyd.26–29 Hhyd has
been identified only recently, thanks to genetic alteration of
specific conserved amino acids which was found to perturb
the distribution of the H-cluster redox states.7,26,28 There is
agreement that Hhyd exhibits a [4Fe4S]1+-Fe(II)Fe(II) configur-
ation with an axial hydride ligand and a bridging CO. More
recently, it has been proposed that the second proton required
to complete H2 synthesis may transiently bind to the aza-
dithiolate bridge, resulting in the intermediate HhydH+ with a
configuration of [4Fe4S]2+-Fe(I)Fe(II).30,31
Separate protonation events have been proposed to take
place on the cubane sub-cluster of the catalytic centre, resulting
in a duplicate set of alternatively protonated redox states which
have been termed HoxH, HoxHCO, Hred′H and HhydH.15,21,22,32
The H-cluster redox states and reactivity have been exten-
sively investigated in model enzymes, particularly CrHydA1
(from the green alga Chlamydomonas reinhardtii), CpI (from
the anaerobic nitrogen-fixing bacterium Clostridium pasteuria-
num) and DdH (from the sulfate-reducing bacterium
Desulfovibrio desulfuricans).2,3,33 CaI (from the solvent-produ-
cer Clostridium acetobutylicum) has a high degree of homology
with CpI and has likewise been characterised.14,34 The main
difference between these enzymes is their domain compo-
sition: CrHydA1 consists of a single domain hosting the
H-cluster only, while DdH and CpI/CaI include additional iron
sulfur centres (2 and 4, respectively) which act as electron relay
chains (commonly referred to as the F-domain).
Generating [FeFe]-hydrogenase crystals enriched in specific
redox states may allow significant progress towards elucidating
the exact structure of the key reaction intermediates by X-ray
diffraction,35 but obtaining a sufficiently high level of hom-
ogeneity for individual redox states is challenging.36
The use of chemical oxidants or reductants to modulate the
redox state in crystals is convenient for simple proteins but
has limitations when a complex catalytic cycle with many poss-
ible intermediates is involved, as with [FeFe]-hydrogenases.
These intermediates usually coexist in a dynamic equilibrium
at proportions defined by the given system parameters.
Indeed, there have been only two reports of reduced [FeFe]-
hydrogenase crystal structures. In the first case, DdH was
treated with high pressure H2 and reduction of the crystal was
demonstrated by UV-VIS spectroscopy, but this did not provide
exact information regarding the precise redox configuration of
the H-cluster.37 In the second case, CpI was treated with sodium
dithionite as reducing agent, but no spectroscopic evidence was
presented to verify or characterise the H-cluster state.38
In order to investigate what redox states of the H-cluster can
be populated in [FeFe]-hydrogenase crystals, and how this
process can be precisely controlled, we extend the previous
work carried out on single crystals of a [NiFe]-hydrogenase.39
Here we show that it is possible to apply electrochemical
control to single crystals of [FeFe]-hydrogenase CpI, with sim-
ultaneous in crystallo monitoring of the H-cluster speciation by
infrared (IR) microspectroscopy (Fig. 2). IR sampling is particu-
larly well suited for this purpose because of its ability to
specifically detect vibrational features of the intrinsic CO/CN−
ligands at the active site of hydrogenases, which are sensitive
to changes in electron density at the metallo-site.
These results, in conjunction with our recent paper on the
[NiFe]-hydrogenase, E. coli Hyd1,40 demonstrate that this tech-
nique has broader applicability to complex metalloenzymes.
Experimental
Preparation of CpI crystals
Clostridium pasteurianum hydrogenase I (CpI) was over-
expressed in E. coli, artificially maturated in vitro, and crystal-
Fig. 1 Top, schematic representation of the H-cluster structure in the
oxidised Hox state. Bottom, schematic representation of the principal
H-cluster redox states and the electron and proton transfer events
leading to corresponding state transitions.
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lised according to previously described protocols.32,41 Crystals
from the same batch as those used in this study yielded high
resolution X-ray diffraction data, reaching resolution <2 Å.
Diffraction data confirm the packing pattern previously
reported for other structures of CpI with space group (P1211)
and almost identical unit cell dimensions.41
IR microspectroscopy under electrochemical control
CpI crystals were gently resuspended in their mother liquor
(22% PEG4000, 0.1 M MES buffer pH 6, 0.4 M MgCl2 and 18%
glycerol) under the inert N2 atmosphere of an anaerobic glove
box (Glove Box Technology, UK). For experiments performed at
pH 8, crystals were resuspended in 0.1 M Tris buffer pH 8.0,
likewise supplemented with 22% PEG4000, 0.4 M MgCl2 and
18% glycerol. For control experiments with CpI in solution, the
buffer composition was either 0.1 M MES-NaOH (pH 6.0) or
Tris-HCl (pH 8.0) supplemented with 0.1 M NaCl and the
enzyme concentration was 0.7–0.9 mM.
All samples were further supplemented with a mixture of
redox mediators to facilitate electron transfer between the
working electrode and the protein crystal, covering the poten-
tial range between −600 and −200 mV vs. the Standard
Hydrogen Electrode (SHE).13,42 The mixture consisted of
0.5 mM each Eu(III) BAPTA (Em = −650 mV), methyl viologen
(Em = −449 mV), benzyl viologen (Em = −329 mV) and anthra-
quinone-2-sulfonate (Em6 = −180 mV; Em8 = −276 mV, where
Em6 refers to the midpoint potential at pH 6.0 for example).
Also, 0.4 mM reduced myoglobin (from equine skeletal
muscle, Sigma) was added to scavenge any traces of O2.
Subsequently, the sample was transferred to a custom-built
gas-tight spectroelectrochemical cell (Fig. 2) that was opti-
mised from a previous report.39 In this cell, the sample sits on
a flat surface featuring a mirror polished glassy carbon disk
working electrode, a carbon ring counter electrode, and a leak-
free Ag/AgCl reference electrode (Innovative Instruments Inc,
USA). The cell is sealed by a CaF2 window (1.5 mm thickness,
Crystran, UK) with a 25 µm PTFE spacer (Pike Technologies,
USA). The reflection mode adopted requires the IR beam to
pass through the crystal twice, doubling the sample path
length. To simplify cross-reference to previous literature,
potentials measured vs. the Ag/AgCl reference electrode were
converted to mV vs. SHE by adding +209 mV, and all potentials
mentioned in the text are quoted vs. SHE.
Electrochemical control was achieved via a Metrohm Autolab
PGSTAT128N potentiostat controlled by NOVA software.
The equilibration time was tested in preliminary kinetics
experiments (Fig. S1†) and fixed to 15 minutes at each poten-
tial in the full potential titrations.
FTIR spectra were recorded with a Bruker Vertex 70
equipped with a Hyperion 2000 microscope, a Globar source,
15× objective and a mercury cadmium telluride (MCT) detec-
tor. Spectra were recorded with a resolution of 2 cm−1 and
averaged from 512 accumulations.
Data analysis
Baseline corrected spectra were obtained by interpolating and
subtracting in OriginLab 2017 a spline baseline to compensate
for the contribution of water to the spectral region of interest
(Fig. S2†). Difference spectra were obtained by directly sub-
tracting raw spectra without further manipulation.
Results and discussion
CpI crystals are stable and the redox control is effective and
fully reversible
In the absence of external electrochemical control, the
H-cluster in CpI crystals equilibrates in a mostly homogeneous
state (Fig. 3A), displaying intense IR peaks at 2082, 2070, 1970,
1947, 1801 cm−1, which are unambiguously assigned to
Hox.28,38,43 Only a minor proportion of other states can be
detected, as indicated by low intensity signals at 2015
(HoxCO), 1975 and 1953 (HoxH), 1937 (Hred) and 1914 cm−1
(HredH+). Traces of HoxCO are commonly observed in spectro-
scopic studies of [FeFe]-hydrogenases.44 Since the contribution
of HoxCO is minimal in the crystal spectra, it will not be taken
into account in the subsequent discussion.
The spectra have excellent signal-to-noise ratio and peak
intensity up to 200 mOD, which is consistent with the high
effective enzyme concentration within the crystal of approxi-
mately 9.4 mM as calculated on the basis of the space group
and unit cell parameters.41 Moreover, the large size of CpI crys-
tals makes it possible to obtain high quality spectra using a
common Globar IR source, while working with smaller crystals
of the [NiFe]-hydrogenase Hyd-1 from Escherichia coli required
Fig. 2 The spectroelectrochemical cell used in this study features a
3-electrode system with mirror-polished glassy carbon working elec-
trode that simultaneously allows for electrochemical control of the
protein crystal and detection by IR spectroscopy in reflection mode. (A)
top view of the cell. (B) a representative CpI crystal as seen by visible
microscopy, highlighting the area sampled by IR spectroscopy. (C)
Schematic cross-section view of the cell (not to scale), including
working electrode (W.E.), counter electrode (C.E.) and reference elec-
trode (R.E.). The electrodes are embedded in a Delrin base plate.
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the use of synchrotron IR radiation, as seen in previous
work.39,40
Microspectroscopy on various CpI crystals from the same
batch shows variations in signal intensity consistent with
differences in shape and size, but overall consistency in the
distribution of redox states (Fig. S3†).
The crystal responds very quickly to an applied potential,
with the equilibration time following a potential step being in
the range of 2–5 minutes (Fig. S1†). Stepping from −200 mV to
−367 mV causes loss of Hox and the increase of several peaks
that reveal the accumulation of reduced species, with HredH+
(1900 cm−1) being the most abundant (Fig. 3B).
Importantly, all changes are fully reversible: stepping back
to −200 mV results in direct reversal of the spectral changes
(Fig. 3C). This clearly demonstrates that CpI in the crystal is
stable in response to the applied potential.
Validating the significance of the H-cluster chemistry in
crystals
In order to validate the results observed in crystals, detailed
redox (potential step) titrations were performed comparing
CpI crystals (Fig. 4A, C and E) with CpI samples in solution
(Fig. 4B, D and F). A high level of comparability was achieved
by using the same IR microspectroscopy cell containing
protein solution instead of crystals.
It should be noted that wild type CpI redox titrations have
not been reported previously, but the data obtained in this
work are consistent with conventional spectroelectrochemical
studies of other [FeFe]-hydrogenases in solution, such as
CrHydA1 and DdH.11,13,45,46
Lowering the potential from −200 to −583 mV in small
steps (17 mV each) confirms that precise electrochemical
control can be achieved, as demonstrated by a gradual decline
of Hox signals while a variety of reduced species appear,
including Hred, HredH+, Hhyd and HsredH+ (Fig. 4).
Also in this case, re-oxidation to −200 mV shows full rever-
sibility of the process both in solution and in crystallo. No
macroscopic damage to the crystal can be detected in visible
images after the titration (Fig. S4†). Appearance of HoxCO can
be an indicator of active site degradation;44 here, enzyme stabi-
lity within individual crystals is further demonstrated by the
fact that only a very low fraction of HoxCO is detectable while
sweeping the potential back and forth during experiments over
12 hours.
In solution it is impossible to achieve the same H-cluster
density as in the crystal; the protein has been concentrated to
approximately 0.9 mM and, consequently, the signal intensity
and signal-to-noise ratio are much lower. Despite this techni-
cal limitation, the redox titration of CpI in solution indicates
very similar speciation as observed for the crystal (compare
Fig. 4B with A).
The same redox species can be observed, as peak positions
and relative peak intensity patterns are identical. The titration
plots show remarkable similarity (compare Fig. 4D with C and
Fig. 4F with E), with minor differences only detectable at
potentials below the H+/H2 redox couple, where the relative
distribution of reduced states is slightly different. This may be
due to differences in accumulation of H2 and in the local con-
centration of protons. Both factors are expected to be particu-
larly influential in the confined space between molecules in a
densely packed protein crystal.
Moreover, when the same experiment is performed at pH 8,
the data gained from crystallised and dissolved CpI show strik-
ing resemblance (Fig. S5†).
These results demonstrate that the functionality of CpI in
the crystalline state is fully retained and supports the signifi-
cance of the mechanistic implications described below.
Dissecting the reduced states in CpI
Since previous IR peak assignments for CpI have only been
made by comparison to already assigned spectra of other
[FeFe]-hydrogenases,28,32 the identification and interpretation
of some of the reduced species observed during redox titration
experiments require a more detailed analysis, now being poss-
ible given the excellent signal-to-noise ratio of the in crystallo
spectra.
As discussed below, on the basis of the redox titrations at
different pH (namely 6 and 8, Fig. 4 and S5† respectively),
several low intensity signals can be conveniently dissected
here, resulting in an updated assignment of IR signatures for
each redox state in CpI, as summarised in Table 1. For clarity
in the figures and the discussion, the most isolated (i.e. non-
overlapping) and intense peak was identified for each species
and used as a unique marker (shown in bold in Table 1).
At pH 6, it is clear that the redox landscape can be divided
into three regions (Fig. 4C and E): (1) at high potentials (i.e.
Fig. 3 IR microspectroscopy of a single CpI crystal in its mother liquor.
(A) spectrum of the untreated crystal with no applied potential (open
circuit potential: approx. −200 mV). (B) Difference spectrum of the
crystal after applying a potential of −367 mV (reduced minus oxidised).
(C) Difference spectrum upon stepping back to −200 mV (re-oxidised
minus reduced). Peaks marked by red wavenumber labels belong to the
IR-signature of Hox.
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Fig. 4 Comparison of redox titrations of CpI at pH 6, in crystallo (left column) and in solution (right column). The oxidised sample was reduced in
steps from −200 mV to −583 mV. The sample was equilibrated for 15 minutes at each given potential. Each given potential is reported in the legend
in mV. The top panels present baseline-corrected spectra obtained from (A) a CpI crystal or (B) a CpI solution. The inset shows a visible image of the
crystal used. The middle panels present 2D plots of the titration for (C) the crystal or (D) the enzyme in solution. The bottom panels present titration
plots for selected wavenumber positions representing each redox state for (E) the crystal or (F) the enzyme solution. For a detailed description of the
peak assignments see the main text and refer to Table 1.
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−200 to −250 mV) the sample is essentially composed of Hox;
(2) at moderately reducing potentials (i.e. −250 to −425 mV),
Hox is converted into a complex mixture of multiple redox
states that accumulates, reaches a maximum at −367 mV and
then is depleted; (3) at more negative potentials (i.e. below
approximately −425 mV) a new complex mixture of further
reduced species is accumulated, replacing the previous pool.
Spectra representative of each of these regions are presented in
Fig. S7.†
The same features are observed in redox titrations at pH 8
(Fig. S5A, S5C and S5E†). All species appear with the same
spectral signature and all redox transitions are shifted, as a
result of the lower availability of protons and corresponding
shifts in the proton-coupled redox equilibria. This demon-
strates that CpI crystals efficiently equilibrate when being
soaked in buffers with a modified composition.
The HredH+ family
Within the moderate reduction potential range (see also
Fig. S8A†), four main peaks reach a maximum abundance at
−367 mV and are readily assigned to HredH+ (2054, 2039, 1915
and 1900 cm−1). It is impossible to unambiguously locate the
fifth peak, as this is expected to be overlapping with more
intense signals from Hox (either in the region around 1970 or
1800 cm−1) and thus it is difficult to further comment on the
coordination state of µCO in the HredH+ state solely on the
basis of the presented IR data. Future work at cryogenic temp-
erature may help to clarify this aspect by analogy to recent
research performed on [FeFe]-hydrogenases in frozen
solution.14,24,47
Interestingly, peaks at 2039, 1922 and 1895 cm−1 (that were
previously suggested to correspond to HsredH+ in CpI)28
coexist with HredH+ (1900 cm−1) signals, precisely following
the same potential dependence plot (Fig. 4E and S6C†) and
being depleted at more negative potentials (i.e. lower than
−500 mV). Because of the similar redox behaviour and similar
wavenumber position (marker peaks 1900 and 1895 cm−1), we
propose that these signals belong to another version of
HredH+ and that these two related species could be classified
as a “family” (Fig. 5).
The two related redox species might only differ in minor
ways, such as protonation state. For example, Ratzloff et al.14
proposed that a 1894 cm−1 species in the structurally related
[FeFe]-hydrogenase CaI represents an unprotonated form of
HredH+ (1899 cm−1 in CaI) with the same formal electron con-
figuration [4Fe4S]2+-Fe(I)Fe(I). Alternatively, computational
studies by Senger et al.22 suggested that further protonation
events at a cysteine coordinating the cubane sub-cluster may
result in IR signatures of the H-cluster being collectively blue-
shifted by 4–8 cm−1.
It should also be noted that in earlier studies of CrHydA1
and DdH a single HredH+ species was consistently
reported,11,13 but recent time-resolved studies of CrHydA1
revealed a similar level of complexity in this spectral region
with two species evident with peak maxima at 1891 and
1896 cm−1.48
Further evidence for a differential protonation state of these
two related species is provided by comparing the relative abun-
dance of each during titrations at different pH values (pH 6 vs.
8, Fig. 5). In both cases, marker peaks 1900 and 1895 cm−1
(and the other peaks associated with the signature) coexist and
Table 1 Summary of the IR signatures for the H-cluster redox states in
CpI. The peaks highlighted in bold are considered unique markers for
each redox state and are used as a reference in the text and in titration
plots (Fig. 4E and 4F)
Redox state
Peak position (cm−1)
CN ligands CO ligands
Hox 2082, 2070 1970, 1947, 1801
HoxH NA, NA 1975, 1953, NA
HredH+ family 2054, 2039 1915, 1895, NA
2054, 2039 1922, 1900, NA (additional H+)
Hhyd family NA, NA 1978, 1962, 1851 (Hhyd:red)
NA, NA 1984, NA, 1856 (HhydH+)
NA, NA 1989, 1958, 1867 (Hhyd:ox)
Hred 2078, 2064 1938, 1788, NA
HsredH+ 2048, 2029 1889, NA, NA
HoxCO 2090, 2076 2015, 1973, 1969, 1807
NA refers to peaks that are expected but could not be unambiguously
identified or assigned; missing bands are reasonably overlapping with
other more intense signals and thus are common to different redox
states. Titration plots for every peak and species are available in
Fig. S6.†
Fig. 5 Dissecting the protonated reduced states in CpI crystals.
Zooming into specific spectral regions reveals marker peaks associated
with single species. (A) from titrations at pH 6. (B) from titrations at pH 8.
Colour legend is the same as Fig. 4A.
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follow the same titration plot, with maximum abundance at
−367 mV at pH 6 or −450 mV at pH 8 (compare Fig. 4E and
Fig. S5E†). However, the relative proportion of the two species
is different: at low pH, the signal at 1900 cm−1 is significantly
more intense relative to the other one (A1900/A1895 is 2.03 at pH
6 and 1.38 at pH 8), and a similar difference is observed when
titrating CpI in solution (Fig. 4B and S5B†). This suggests that
the species represented by the peak at 1900 cm−1 is more pro-
tonated than the one with the 1895 cm−1 marker band (Fig. 5).
This interpretation is also in agreement with previous reports
on CaI.14
The Hhyd family
The other low intensity sets of signals observed in the moder-
ate reduction potential range (maximum abundance at
−367 mV) of the titration at pH 6 (i.e. 1989–1958–1867 and
1984–1856 cm−1) are in good agreement with previous reports
on Hhyd, and they are all depleted at more negative potentials
(below −400 mV), being converted into the more intense signa-
ture 1978–1962–1851 cm−1. Peaks arising from the cyanide
ligands cannot be unambiguously assigned due to overlap
between Hox and Hred signals in the region between
2065–2085 cm−1.
We propose to classify these three IR signatures as a
“family” of Hhyd species (Fig. 5). Small spectral differences
here might arise from minor structural variations, such as a
different protonation state/position or from deviations in the
electronic configuration such as a reduced or oxidised [4Fe4S]
cluster.
The existence of multiple Hhyd species has also been pro-
posed before: three CO stretching IR bands were originally
detected for the C169S variant of CrHydA1 (1874, 1868,
1860 cm−1).7 More recently, a similar degree of diversity has
been reported in wild type CrHydA1: two species were detected
in vivo (1875, 1860 cm−1)31 and three species were differen-
tiated at cryogenic temperatures (1865, 1861, 1851 cm−1).49
Furthermore, two different Hhyd species have been observed
in wild type CaI (1856, 1852 cm−1);14 and CpI (1870,
1856 cm−1).32
On this basis we assign the most abundant species (associ-
ated with the 1851 cm−1 peak) to “conventional” Hhyd26–29
(also known as Hhyd:red)49 and the 1867 cm−1 species to
Hhyd:ox (configuration [4Fe4S]2+-Fe(II)Fe(II)).49 Interestingly,
Hhyd:ox is highly similar to a new species which was denoted
HredH+ in a recent computational study.50 In CpI crystals, the
1856 cm−1 species is completely undetectable at pH 8 (Fig. 5
and Fig. S5†), suggesting an assignment for this species as the
more protonated state HhydH+. Consistently, previous experi-
ments with CpI in solution at pH 4 only displayed this spectral
signature.28,32
Despite significant accumulation of numerous reduced
species possibly differing in protonation state, we do not
observe significant accumulation of HoxH and this is consist-
ent with previous reports that this species accumulates only at
low pH (≤6) and exclusively in the presence of sodium
dithionite.22
A notable observation is that wild type CpI (both in crys-
tallo and in solution) readily accumulates a relevant
amount of Hhyd species under electrochemical control and
mild pH conditions. To the best of our knowledge, this is
the first time that Hhyd has been observed under such
experimental conditions. Hhyd was undetectable in pre-
vious spectroelectrochemical solution-based experiments
with CrHydA113,46 or DdH,11,45 and could only be detected
at very low pH28 or in enzyme variants with impaired
proton reduction activity.26,30,32 The only other case of a
wild type [FeFe]-hydrogenase accumulating Hhyd at pH 8 is
CaI when treated with dithionite.14 The different propen-
sity to accumulate Hhyd species will be investigated in
future by systematically comparing different [FeFe]-hydro-
genases and variants under the same experimental
conditions.
Hred and HsredH+ assignment
In addition to Hhyd species, at more negative potentials
several other peaks arise (see also Fig. S8B†). Considering the
titration plots and on a comparative basis, these can be
assigned to Hred (2078, 2064, 1938 and 1788 cm−1) and
HsredH+ (2048, 2029 and 1889 cm−1). Here again, it is imposs-
ible to unambiguously assign all five peaks for each redox
state, as the missing peaks overlap with other more intense
peaks in the crowded regions of the spectrum (i.e. 1940–1990
and/or 1780–1800 cm−1).
The accumulation of HsredH+ follows a similar trend at pH
6 and pH 8, where it appears at approximately −433 mV and
then increases at lower potentials (Fig. 4E, S5E† and Fig. 5).
This provides unambiguous assignment of the 1889 cm−1
marker peak to HsredH+, improving the previous characteris-
ation of this species in clostridial hydrogenases.14,28,32
The titration plots of Hred vary significantly at different pH
values. At pH 6, HredH+ reaches a maximum at −367 mV and
then decreases, while Hred is most abundant below −533 mV
(Fig. 4); at pH 8, HredH+ abundance reaches a maximum at
−450 mV, while Hred is most abundant at −417 mV (Fig. S5†).
Also in this case, there is significant agreement between
experiments performed in crystallo and in solution. The coun-
terintuitive formation of Hred at potentials lower or higher
than HredH+, as a function of pH, is in marked contrast with
previous studies on CrHydA1,13 where they coexist at the same
potentials, but it correlates extremely well with studies on
DdH.11,21 The fact that CpI features this behaviour is likely due
to redox anti-cooperativity between the H-cluster and the proxi-
mal F-cluster (present in both CpI and DdH but absent in
CrHydA1).
Some of the IR signals discussed above have been proposed
to be due to the incorporation of a degraded form of the syn-
thetic precursor [2Fe]adt in DdH (namely 1988 and
1921 cm−1).11 However, since these peaks are redox active in
our titrations and, more importantly, they were previously
observed in CaI produced via in vivo maturation with the
maturases HydEFG,14,34 it is more likely that they have a func-
tional role.
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In summary, this work demonstrates that it is possible to
control, electrochemically, the redox state of [FeFe]-hydrogenase
crystals, and to probe the H-cluster simultaneously by IR micro-
spectroscopy. Numerous reduced states can be generated in crys-
tallo, showing that it is possible to cycle through all catalytically
relevant states: Hox, Hred, HredH+, Hhyd and HsredH+.
Control experiments performed on the enzyme in solution
display the same spectral features, demonstrating that CpI
behaves in the same way when it is tightly packed in the ordered
crystal structure, further supporting the significance of previous
and future structural studies. Furthermore, the accumulation of
complex redox mixtures upon reduction highlights the impor-
tance of probing the redox composition of [FeFe]-hydrogenase
crystals when performing structural diffraction studies.
The high sensitivity of this technique, and the possibility to
finely tune the redox state by changing the potential in a
highly controlled manner allow for the detection and discrimi-
nation of species that only exist within a narrow window of pH
and potential conditions. This has allowed the identification
and assignment of Hhyd:red (1851 cm−1), HhydH+
(1856 cm−1), Hhyd:ox (1867 cm−1) in CpI, in addition to a new
alternative version of HredH+ (1895 cm−1) that is characterised
here for the first time. Moreover, an unambiguous assignment
for HsredH+ in CpI was obtained (1889 cm−1).
In accordance with recent reports by others, our data show
that various alternative redox states with similar spectral signa-
tures coexist in [FeFe]-hydrogenases (families of states), these
could be due to changes in the protonation state and location,
the long-range effects of the F-cluster redox state, or other fine
local structural changes.
This work provides a roadmap for enriching and confirm-
ing the presence of specific redox states in [FeFe]-hydrogenase
crystals.
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